Abbvie Stock News

Brown Miller Wealth Management LLC raised its stake in AbbVie Inc. (NYSE:ABBV) by 1.9% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 16,707 shares of the companys stock after purchasing an additional 315 shares during the period. AbbVie accounts for approximately 1.1% of Brown Miller Wealth Management []

Stewart & Patten Co. LLC decreased its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 26.6% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,350 shares of the company’s stock after selling 1,215 shares during the period. Stewart & Patten Co. LLC’s holdings in AbbVie […]

Wolf Group Capital Advisors decreased its position in AbbVie Inc. (NYSE:ABBV) by 1.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 16,679 shares of the company’s stock after selling 325 shares during the quarter. Wolf Group Capital Advisors’ holdings in […]

ProVise Management Group LLC trimmed its stake in AbbVie Inc. (NYSE:ABBV) by 14.1% in the third quarter, HoldingsChannel.com reports. The firm owned 64,156 shares of the companys stock after selling 10,508 shares during the period. ProVise Management Group LLCs holdings in AbbVie were worth $6,920,000 at the end of the most recent quarter. A number []

Virginia Retirement Systems ET AL lifted its position in AbbVie Inc. (NYSE:ABBV) by 64.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 401,953 shares of the companys stock after purchasing an additional 157,300 shares during the quarter. Virginia Retirement Systems ET ALs []

Sugarloaf Wealth Management LLC lifted its holdings in AbbVie Inc. (NYSE:ABBV) by 8.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,879 shares of the companys stock after acquiring an additional 634 shares during the period. Sugarloaf Wealth Management LLCs holdings []

Chevy Chase Trust Holdings Inc. decreased its position in shares of AbbVie Inc. (NYSE:ABBV) by 3.6% in the 3rd quarter, Holdings Channel reports. The firm owned 1,127,938 shares of the companys stock after selling 42,718 shares during the quarter. Chevy Chase Trust Holdings Inc.s holdings in AbbVie were worth $121,671,000 at the end of the []

NORTH CHICAGO, Ill., Dec. 3, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced an update to the U.S. Prescribing Information and Medication Guide for RINVOQ® (upadacitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA). This update follows a Drug…

Smith Anglin Financial LLC trimmed its position in shares of AbbVie Inc. (NYSE:ABBV) by 7.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,086 shares of the company’s stock after selling 253 shares during the period. Smith Anglin Financial […]

Pinnacle Associates Ltd. raised its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 4.8% in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 54,879 shares of the companys stock after acquiring an additional 2,521 shares during the period. Pinnacle Associates Ltd.s holdings in AbbVie were worth $5,920,000 []

Seelaus Asset Management LLC cut its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 13.0% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,100 shares of the companys stock after selling 463 shares during the period. Seelaus Asset Management LLCs []

Cambridge Advisors Inc. decreased its position in AbbVie Inc. (NYSE:ABBV) by 2.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 11,385 shares of the companys stock after selling 231 shares during the period. Cambridge Advisors Inc.s holdings in AbbVie were worth []

Gemmer Asset Management LLC lowered its stake in AbbVie Inc. (NYSE:ABBV) by 4.1% in the 3rd quarter, HoldingsChannel reports. The fund owned 3,738 shares of the companys stock after selling 158 shares during the period. Gemmer Asset Management LLCs holdings in AbbVie were worth $403,000 at the end of the most recent quarter. A number []